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Synovial sepsis of unknown origin is a rare cause of lameness in the adult horse and 28 
a haematogenous pathogenesis has been proposed in previous cases. 29 
Objectives 30 
To describe the features and outcome of synovial sepsis of unknown origin in adult 31 
Thoroughbred racehorses.  32 
Study Design 33 
Retrospective series of cases admitted between 2005 and 2015. 34 
Methods 35 
Hospital records were reviewed to identify adult horses diagnosed with synovial 36 
sepsis of unknown origin. Presentation, clinicopathological, microbiological and 37 
diagnostic imaging findings were recorded. Treatment methods, surgical findings, 38 
complications and long-term outcome were evaluated.  39 
Results 40 
Eleven cases were identified over the study period. Diagnosis was established from 41 
clinical examination and clinicopathologic findings, which were comparable to other 42 
aetiologies of synovial sepsis. Affected structures included synovial joints, tendon 43 
sheaths and bursae. Concurrent osteochondritis dissecans or articular cartilage 44 
lesions were evident during arthroscopic surgery in 3 cases. Significant intrasynovial 45 
haemorrhage was not identified. Microbial culture of synovial fluid or synovial biopsy 46 
was positive in 6/11 of cases, with all isolates being Gram-positive cocci. Of the 6 47 
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positive microbial cultures, all isolates demonstrated in vitro sensitivity to a 48 
cephalosporin antimicrobial agent.  A concurrent remote wound was present in a 49 
single case. No other potential origins of bacteraemia were identified. Treatment 50 
methods included endoscopic surgery, standing multi-needle lavage, intravenous 51 
regional limb perfusion, intrasynovial medication and/ or systemic antimicrobial 52 
administration.  All horses survived to hospital discharge. For the 6/11 cases that 53 
raced following synovial sepsis, the median period for return to racing was 221 days. 54 
Main Limitations 55 
A small study population, which was retrospectively reviewed. 56 
Conclusions 57 
Synovial sepsis of unknown origin is rare in the adult Thoroughbred racehorse and 58 
can affect a range of synovial structures. A concurrent potential source of 59 
bacteraemia is rarely identified. With appropriate management the prognosis to 60 




Synovial sepsis is a frequently encountered and significant problem in the horse 63 
[1,2]. Bacterial inoculation and colonisation of the synovial cavity and the subsequent 64 
stimulation of inflammatory and degenerative cytokine mediators can result in 65 
substantial irreversible damage to the synovium and articular cartilage [3]. 66 
In adult horses the most frequent causes of synovial sepsis are penetrating trauma 67 
and iatrogenic contamination by intrasynovial injection or surgical procedures [1,3–68 
11]. Haematogenous localisation of bacteria to multiple synovial structures is 69 
common and well documented in foals [5,12,13].  70 
Limited reports of haematogenous synovial infection in adult horses involved the 71 
development of synovial sepsis with a concurrent remote focus of microbial infection, 72 
which was suspected to have acted as an origin of bacteraemia [14–16]. Synovial 73 
sepsis of unknown origin is sporadically identified in adult horses and typically 74 
involves a single synovial structure [3]. The designation idiopathic synovial sepsis 75 
has been used to describe cases with an unidentified route or causative agent. 76 
However, the term synovial sepsis of unknown origin is utilised in this study as it 77 
more accurately describes cases with an established synovial microbial isolate but 78 
where the route of sepsis is unestablished. When the cause of synovial sepsis is 79 
unknown there is reported to be a reduced likelihood of survival [17]. These cases 80 
typically present without an obvious origin of bacteraemia, though a haematogenous 81 
route is often implicated [1,6,18–22]. There is limited information characterising 82 
synovial sepsis of unknown origin in adult Thoroughbred racehorses, including the 83 
pathogenesis, treatment and prognosis for future racing. The objectives of this 84 
retrospective case series were to describe the presentation, clinicopathological 85 
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features, surgical findings, treatment and long-term outcome of synovial sepsis of 86 
unknown origin in adult Thoroughbred racehorses.  87 
Materials and Methods 88 
Case Selection/ Inclusion criteria 89 
Medical records were searched retrospectively to identify Thoroughbred racehorses 90 
(two-year-olds or older) with synovial sepsis admitted to Randwick Equine Centre 91 
over a 10-year period, from 2005 to 2015.  92 
Hospital records of the cases were reviewed to remove cases with known causes of 93 
synovial sepsis from the study. Exclusion criteria included historical evidence of a 94 
wound to the affected structure, surgery of the affected structure within the previous 95 
year, a peri-synovial septic focus and/or synoviocentesis in the 30 days preceding 96 
synovial sepsis. A diagnosis of synovial sepsis required synovial fluid analysis 97 
demonstrating a nucleated cell count ≥30.0 x109 cells/L, neutrophil differential 98 
percentage ≥80% and total protein (TP) ≥40 g/L or one of these parameters in 99 
addition to a positive microbiological culture of synovial fluid or synovial biopsy.  100 
Presentation 101 
Recent exercise history and duration from presentation and referral to diagnosis of 102 
synovial sepsis were collated. In addition, data collected included age, gender, 103 
affected limb and synovial structure(s). Clinical findings at presentation included 104 
rectal temperature, degree of lameness using the AAEP grading scale [23] and the 105 
presence, location and degree (subjectively rated as none, mild, moderate or 106 
marked) of synovial effusion.  107 
Clinical Pathology 108 
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Synovial fluid samples were evaluated for total nucleated cell count, neutrophil 109 
differential percentage, red blood cell count, total protein content and presence of 110 
bacteria on cytological examination. Synovial fluid or surgical biopsy samples were 111 
collected and submitted in Cooked Meat Mediuma for aerobic and anaerobic 112 
microbial culture. When acquired, samples for peripheral blood culture were 113 
submitted for aerobic and anaerobic microbial culture. Microorganisms isolated were 114 
examined for morphology and Gram stain. Microbial isolates were identified to a 115 
species level using a combination of mass spectrometry (VITEK MS)b, automated 116 
(VITEK 2)b and manual (API 20 Strep)b biochemical methods as required. Any 117 
samples with a positive microbial culture were submitted for antimicrobial 118 
susceptibility testing. Haematological and biochemical parameters assessed on 119 
venous blood samples included the white cell count, neutrophil differential 120 
percentage, total serum protein content and fibrinogen.  121 
Diagnostic Imaging 122 
Radiographic, ultrasonographic and scintigraphic findings of the affected regions 123 
were reviewed and classified as either related to synovial sepsis or from a different 124 
primary disease process.  125 
Treatment 126 
Pre-referral treatments were noted. Any procedures undertaken prior to admission 127 
were recorded including synoviocentesis, intrasynovial antimicrobial medication and 128 
standing multi-needle lavage.  129 
Hospital treatment was categorised as arthroscopic, tenoscopic or bursoscopic 130 
surgery under general anaesthesia, standing multi-needle lavage, intravenous 131 
regional limb perfusion (IVRLP), intrasynovial antimicrobial administration or other. 132 
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For each case the frequency of the procedure was recorded and where relevant, the 133 
antimicrobial agent utilised was recorded. The duration of treatment was 134 
documented for each systemic antimicrobial utilised. Complications occurring during 135 
hospitalisation were also documented. 136 
Outcome 137 
Short term outcomes included the duration of hospitalisation, survival to hospital 138 
discharge, treatment recommendations after discharge and hospital re-admissions 139 
related to synovial sepsis. Long term outcome was determined by review of medical 140 
and race records (Racing NSW: www.racingnsw.com.au). Follow-up was performed 141 
until October 2017, when all horses completed their racing careers. All horses had a 142 
follow up period of at least 2 years following hospital admission.  Outcome data 143 
collected included number of starts, placings and earnings for each case after the 144 
episode of synovial sepsis. The time from hospital admission to return to racing was 145 
recorded. The racing careers of horses exported from Australia were followed until 146 
exportation. 147 
Where available, dates and reasons for retirement from racing or euthanasia were 148 
recorded from medical or Stud Book (Australian Stud Book: www.studbook.org.au) 149 
records. Reasons were classified as either lameness related to the synovial sepsis of 150 
unknown origin, lameness unrelated to synovial sepsis, other medical or 151 
musculoskeletal conditions or retirement to breeding. Where relevant, the date of 152 
euthanasia was recorded.  153 
Data Analysis 154 
The relevant clinical, racing and Stud Book data were compiled into a database 155 
(Microsoft Office Excel 2016)c. The data were assembled into frequency tables, 156 
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evaluated graphically and descriptive statistical analysis was performed. Where 157 
appropriate, clinical and clinicopathological data were grouped relative to defined 158 
normal reference ranges and assembled into frequency tables. For ordinal and 159 
discrete numerical data, analysis included calculation of the median and range. 160 
Analysis of continuous data included calculation of the median, mean and range. 161 
Where distribution of data resulted in similar values for measures of central 162 
tendency, only the mean was reported.  163 
Results 164 
Presentation 165 
Eleven adult Thoroughbred horses were diagnosed with synovial sepsis of unknown 166 
origin from 2005 to 2015. The median age at presentation was 2 years (range 2-6 167 
years). There were 5 fillies/mares, 2 colts/stallions and 4 geldings. At the time of 168 
presentation 7/11 horses were unraced. A forelimb was involved in 4/11 and 169 
hindlimb in 7/11 cases. A summary of case details is presented in Table 1. 170 
The femoropatellar joint accounted for 3/11 cases and the digital flexor tendon 171 
sheath and metacarpo/metatarsophalangeal joint accounted for 2 cases each. The 172 
remaining 4 cases involved the antebrachiocarpal joint, tarsocrural joint, bicipital 173 
bursa and tarsal sheath. A lameness grade was not available for 1 horse, though all 174 
other cases demonstrated a grade 3/5 or greater lameness during at least one 175 
examination. The median lameness grade at initial presentation was grade 4/5 176 
(range 0-5/5).  Rectal temperature was recorded in all horses during at least one 177 
initial examination. At presentation the mean rectal temperature was 38.7 oC (range 178 
37.8 to 40.4oC). Pyrexia was identified in 7/11 cases (rectal temperature >38.5oC). 179 
Degree of synovial effusion was recorded in 9 cases, ranging from no effusion to 180 
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marked effusion, with 8/9 horses having moderate or marked effusion at 181 
presentation.  182 
A diagnosis of synovial sepsis was achieved prior to referral in 2/11 cases. The 183 
mean duration from presentation to diagnosis was 2 days (median 1 day, range 1-4 184 
days).  No horses had a history of synoviocentesis or medication of the affected 185 
synovial structure prior to presentation. Case 5 presented as a 2-year-old and had 186 
yearling sale radiological records indicative of previous surgery of the affected 187 
femoropatellar joint but no other horses had historical evidence of surgery of the 188 
affected synovial structure. A single case had clinical signs of a potential concurrent 189 
remote site of infection with a wound on the ipsilateral hoof coronary band. At the 190 
time of presentation 9/11 horses were in training or pre-training, with 1 horse 191 
undergoing paddock rest and the status not reported in a single case. Four horses 192 
had performed trot/canter work in the previous 24 hours and 1 horse had not worked 193 
for the preceding 48 hours. In the remaining cases details of recent exercise was not 194 
available. 195 
Clinical Pathology 196 
In all cases synoviocentesis and synovial fluid analysis was performed on the 197 
affected structures. Arthrocentesis was performed in multiple stifle compartments in 198 
case 1 (femoropatellar and lateral femorotibial joints) and case 5 (femoropatellar, 199 
medial femorotibial and lateral femorotibial joints). In these cases, the synovial 200 
compartment with the greatest elevation of synovial parameters was included in 201 
further analysis. Synovial fluid analysis findings are presented in Table 1. The mean 202 
nucleated cell count was 82.0 x109 cells/L (median 71.0 x109 cells/L and range of 203 
12.4- 166.0 x109 cells/L). Neutrophil differential percentage was performed in all 204 
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cases with a mean of 90% (median 94% and range of 80-96%). Total protein content 205 
was evaluated in all samples, with a mean of 48 g/L (range of 39-60 g/L). One 206 
sample was noted as grossly haemorrhagic. A red blood cell count was performed in 207 
9 cases, with a mean of 0.04 x1012 cells/L (range 0 – 0.08 x1012 cells/L). 208 
Gram stain cytology was performed in 10/11 cases. Gram-positive cocci were 209 
identified in a single sample, however, in the remaining preparations no micro-210 
organisms were observed. Aerobic culture was positive in 6/11 cases. All isolates 211 
were Gram-positive cocci with antimicrobial susceptibility patterns shown in Table 2. 212 
Three horses received antimicrobial therapy prior to referral and in 2/3 cases 213 
synovial fluid culture was positive. A synovial tissue sample was submitted for 214 
microbiological culture in a single case but no growth occurred. 215 
Haematology and biochemistry were performed in 9/11 cases. The white blood cell 216 
count was elevated (>10 x109 cells/L, lab reference range 6 - 10 x109 cells/L) in 5/9 217 
cases with a mean count of 11.0 x109 cells/L (range 5.9-16.6 x109 cells/L). The mean 218 
total plasma protein was 68 g/L with a range of 63-74 g/L (lab reference range 57-70 219 
g/L).  In 10 cases the neutrophil percentage and fibrinogen were also recorded, with 220 
means of 74% (range 52-84% and lab reference range 48-68%) and 4 g/L ( range 3-221 
5 g/L and lab reference range 0-4 g/L), respectively. Venous blood culture was 222 
performed in one case, which was negative. 223 
Diagnostic Imaging 224 
Radiography of the affected region was performed in all cases. Pathology was 225 
identified in 3/11 cases. In case 6 markedly increased soft tissue opacity surrounding 226 
the affected metacarpophalangeal joint was suspected to be secondary to synovial 227 
sepsis. In cases 5 and 7 osteochondritis dissecans lesions were categorised as pre-228 
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existing intra-articular radiographic abnormalities. Case 7 had a large, previously 229 
operated osteochondritis dissecans lesion on the lateral trochlear ridge of the femur 230 
with a small osteochondrosis lesion on the medial trochlear ridge. A small 231 
osteochondral fragment was evident on the craniolateral aspect of the femoropatellar 232 
joint. 233 
Ultrasonography was performed in 5/11 cases, with findings attributable to synovial 234 
sepsis identified in all ultrasonographic studies [24]. In 3 studies, hyperechoic 235 
material consistent with fibrin or pannus formation was identified within the synovial 236 
structure. Case 6 demonstrated a grade 4/4 (scale adapted from [25]) lateral 237 
suspensory branch core lesion, which extended peripherally and to the distal 238 
insertion of the branch with a small, non-articular abaxial avulsion fragment from the 239 
lateral proximal sesamoid bone. Scintigraphy was performed in case 9, 240 
demonstrating mild generalised increased radiopharmaceutical uptake of the 241 
cranioproximal humerus during the bone phase, with ultrasonography revealing 242 
effusion of the bicipital bursa and an irregular synovial margin overlying the thecal 243 
surface of the proximal tendon of the biceps brachii muscle. 244 
Treatment 245 
Six cases received treatment prior to hospital referral, which included systemic (3 246 
cases) and intrasynovial (2 cases) antimicrobial therapy. Case 10 underwent 247 
standing multi-needle lavage of the affected tarsocrural joint. Non-steroidal anti-248 
inflammatory therapy was administered prior to referral in 5 cases. Further anti-249 
inflammatory therapies pre-referral included topical dimethyl sulfoxide (case 8) and 250 
intravenous dexamethasone (case 9).  251 
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Treatment methods and procedures are summarised in Supplementary Item 1. 252 
Arthroscopic, tenoscopic or bursoscopic surgery included lavage of the affected 253 
synovial structure performed under general anaesthesia in 9/11 cases. Intrasynovial 254 
fibrin or pannus formation was noted in 8/9 surgical cases. Evidence of traumatic 255 
synovial puncture or foreign material was not evident in any case. Intrasynovial 256 
lesions identified during endoscopic surgery include osteochondrosis lesions and 257 
articular cartilage wear lines. Further details of endoscopic surgery findings are 258 
outlined in Supplementary Item 2. At the end of all procedures, synovial structures 259 
were medicated with an antimicrobial medication.  260 
A standing multi-needle lavage was performed in 6/11 cases. In 4 cases this was 261 
performed in addition to arthroscopic or tenoscopic lavage. Two cases were treated 262 
with 3 sequential multi-needle lavages multi-needle lavage without undergoing 263 
endoscopic surgery. At the end of each procedure the synovial structure was 264 
medicated with an aminoglycoside antimicrobial agent. Antimicrobial IVRLP was 265 
performed using ceftriaxone (1g)d in 3/11 cases. Intrasynovial antimicrobial 266 
medication (performed on a separate occasion to other procedures) was undertaken 267 
in 7/11 horses, with a median of 3 treatments (range 1 to 5).  268 
All cases received systemic antimicrobial therapy, with a mean duration of 17 days 269 
(range 9-34 days). Procaine penicillin G (22 000 iu/kg bwt i.m. q12h, Propercillin)e 270 
and gentamicin sulphate (6.6 mg/kg bwt i.v. q24h, Gentam)e were used in 10 horses. 271 
A single case was treated with ceftiofur (4 mg/kg bwt i.v. q12h, Accent)f and 272 
gentamicin (6.6 mg/kg bwt i.v. q24h,Gentam)e. Six horses were treated with a course 273 
of trimethoprim potentiated sulfadimidine (30 mg/kg bwt p.o. q12h, Sulprim)e after 274 
the primary parenteral antimicrobial agents were discontinued. The decision to 275 
continue antimicrobial therapy was based on clinical progression following treatment, 276 
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which included sequential synoviocentesis and synovial fluid analysis in some cases. 277 
Phenylbutazone was administered on a decreasing regime determined by clinician 278 
assessment of clinical progression, with a mean duration of 9 days (median 4 days 279 
and range 1 -37 days). 280 
Complications occurred during hospitalisation of 3 cases, including jugular 281 
thrombophlebitis, a procaine penicillin hyperexcitability reaction and a foot abscess 282 
(in a different limb to the primary synovial sepsis).  283 
Outcome 284 
All horses were discharged from the hospital, with a mean hospitalisation period of 285 
13 days (range 5-17 days). Three horses developed recurrent sepsis of the affected 286 
synovial structure and a further case developed sepsis of other synovial structures. 287 
Case 9 was re-admitted 29 days after discharge with recurrence of right forelimb 288 
lameness. Further investigation included scintigraphy which demonstrated increased 289 
radiopharmaceutical uptake in the intermediate tubercle of the right humerus during 290 
the bone phase, which was suspected to represent persistence of local infection. A 291 
course of systemic antimicrobials was administered based on previous culture and 292 
susceptibility testing. Case 10 was re-admitted to the hospital at 40 days following 293 
discharge with a recurrence of tarsocrural joint sepsis. Further treatment included a 294 
second arthroscopic lavage procedure, 3 standing multi-needle lavages, 4 IVRLPs, 295 
intrasynovial antimicrobial medication and systemic antimicrobial therapy. The horse 296 
subsequently returned to training before commencing a breeding career. Case 1 was 297 
euthanased one year following hospital discharge due to recurrence of the original 298 
femoropatellar joint sepsis. Case 2 was originally treated for hindlimb digital flexor 299 
tendon sheath sepsis but was readmitted to the hospital 14 days after discharge, 300 
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with bilateral forelimb metacarpophalangeal joint sepsis. An aggressive septic 301 
process was demonstrated radiographically and arthroscopically, with evidence of 302 
osteomyelitis, cartilage degeneration and marked pannus formation. Treatment with 303 
bilateral metacarpophalangeal joint arthroscopic lavage, repeated standing multi-304 
needle lavage and local and regional antimicrobials did not produce a clinical 305 
improvement, resulting in euthanasia.  306 
A total of 6/11 horses raced following synovial sepsis. The mean time to return to 307 
racing was 237 days (median 221 days and range 107- 429 days). Five horses had 308 
five or more race starts post-synovial sepsis. Mean earnings from racing post-309 
synovial sepsis was $63182 (median $1125 and range $0 -$635500). One horse 310 
was retired from training for lameness unrelated to synovial sepsis and 2 for 311 
respiratory abnormalities. Four horses left race training to commence a breeding 312 
career. The reason for retirement for 2 geldings following five or more race starts 313 
was not known. Case 6 was euthanased due to respiratory disease and case 3 was 314 
euthanased for unknown reasons after a career as a broodmare. Therefore, a total of 315 
four horses were reported as deceased in the follow-up period of at least two years 316 
following admission. 317 
Discussion 318 
This study presents data from 11 cases of synovial sepsis of unknown origin in adult 319 
Thoroughbred racehorses admitted over a 10-year period. Most horses were in 320 
training at the time of presentation and a range of synovial structures were affected. 321 
No clear aetiologies of sepsis were identified, therefore, a haematogenous 322 
pathogenesis was suspected. All bacterial isolates were Gram-positive cocci though 323 
no obvious origins of bacteraemia were evident. Treatment with methods typical for 324 
the management of synovial sepsis resulted in a fair prognosis for return to racing. 325 
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Origins of bacteraemia  326 
Haematogenous synovial sepsis has multifactorial pathogenesis, requiring a state of 327 
bacteraemia, which permits the invasion of pathogens into a synovial structure [26]. 328 
The horses in this study were considered immunocompetent, therefore, a transient, 329 
subclinical bacteraemia is suspected. In the present study sepsis involved a single 330 
synovial structure, except in case 2; an unusual case of simultaneous sepsis of 331 
multiple distant structures in an adult horse. Synovial sepsis was generally 332 
monomicrobial and all isolates were Gram-positive cocci. Staphylococcus aureus 333 
has been reported as the most common isolate from equine synovial sepsis [27] and 334 
coagulase positive Staphylococcus spp. accounted for 3/6 of positive cultures in the 335 
present study. However, a range of other pathogens, including Enterobacteriaceae, 336 
have been isolated from cases of suspected haematogenous synovial sepsis 337 
[1,16,26]. The source of bacteraemia is likely to vary between cases of 338 
haematogenous synovial sepsis. 339 
Previously implicated origins of bacteraemia in adult equine synovial sepsis include a 340 
subsolar abscess, septic peritonitis, intra-arterial catheters, infective endocarditis and 341 
distant traumatic and surgical wounds [1,14–16,26]. Staphylococcal spp. are the 342 
most common isolates from traumatic and surgical wounds [28]. A wound remote to 343 
the site of synovial sepsis was evident in a single case of the present study. The 344 
gastrointestinal tract has also been proposed as an origin of bacteraemia in cases of 345 
haematogenous synovial sepsis [26]. Bacteraemia has been associated with 346 
intestinal disease in the adult horse including enterocolitis [29] and small intestinal 347 
lesions requiring resection [30]. However, severe gastrointestinal disease was not 348 
identified in the present study. In humans and horses intense exercise results in 349 
reductions in splanchnic blood flow [31,32], which may result in localised intestinal 350 
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ischaemia, metabolic injury and damage to the intestinal barrier [33]. An 351 
inflammatory response is also stimulated by intense exercise [31], which may 352 
contribute to changes in intestinal integrity [34]. Endotoxaemia due to increased 353 
intestinal barrier permeability during strenuous exercise has been recognised in 354 
human athletes and Thoroughbred racehorses [35,36]. The potential for bacterial 355 
translocation from the gastrointestinal tract during exercise has also been proposed 356 
[37]. Gram-positive cocci, consistent with the synovial isolates from the present 357 
study, were occasionally identified in a study of bacteraemia in horses with diarrhoea 358 
[29]. Other commensal organisms of the gastrointestinal tract have been isolated in 359 
synovial sepsis of suspected haematogenous origin [26]. Bacteraemia has been 360 
reported in equine and human patients following dental extraction [38–40]. Dental 361 
procedures were not evident in the historical findings of this retrospective study.  362 
In human patients bacteraemia is often of unknown origin, though intravenous 363 
catheters are frequently implicated [41]. Ramzan [14] described a case of 364 
haematogenous septic digital flexor tendon sheath tenosynovitis in an adult 365 
Thoroughbred with infective endocarditis, suspected to be secondary to jugular 366 
thrombophlebitis. Similarly, Barr et al. [42] reported haematogenous microbial 367 
inoculation following catheterisation of the dorsal metatarsal artery, leading to 368 
destructive lesions in the proximal sesamoid bones. No cardiovascular abnormalities 369 
were reported at presentation in the current study, though a single case developed 370 
jugular thrombophlebitis following admission. Specific assessment for evidence of 371 
septic cardiovascular disease, in combination with blood culture, may corroborate 372 
the association of lesions such as thrombophlebitis with haematogenous synovial 373 
sepsis. 374 
Mechanisms of synovial invasion 375 
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The vascular supplies of synovial structures are an important consideration in the 376 
mechanism of synovial sepsis of haematogenous origin. The major vascular supply 377 
to the synovial cavity is within the synovium [43]. This partially fenestrated capillary 378 
network [44] is suspected to be the site of entry in synovial sepsis of haematogenous 379 
origin (S type) in foals [45] and the adult horse, particularly if vasculitis is present.  380 
Synovitis due to pre-existing intra-synovial or peri-synovial pathology may act as a 381 
predisposing factor for microbial invasion through this capillary network, into a 382 
synovial structure [46–48]. Case 6 of the present study demonstrated a lateral 383 
suspensory ligament branch insertional avulsion injury and there was no evidence 384 
that this acted as a primary septic focus. Exercise may have a role in this 385 
mechanism by exacerbating local inflammation. Recent exercise has been described 386 
in previous reports of suspected haematogenous synovial sepsis [14,16,19] and 9/11 387 
of horses in the present study were in training or pre-training. Intra-articular 388 
haemorrhage from the synovium has been associated with exercise [49,50] and 389 
could theoretically predispose to bacterial colonisation. However, significant 390 
haemorrhage was not a feature of cases in the present study. A small number of 391 
vessels penetrate from subchondral bone plate into the overlying calcified cartilage 392 
[51]. These channels can be exposed from the articular surface [52]. The pre-393 
existing lesions affecting articular cartilage in the current study are common in this 394 
population and no cases had evidence septic processes affecting adjacent bone. 395 
This method of microbial entry is considered unlikely.  396 
Some intrasynovial structures have additional vascular supplies [53]. Within the 397 
digital flexor tendon sheath the deep digital flexor tendon is supplied primarily by the 398 
mesotenon vascular network [54].  Kidd et al [55] described cases of septic 399 
tendonitis without evidence of pre-existing tendon disruption that were suspected to 400 
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have a haematogenous origin. Features of this disease mirror those of synovial 401 
sepsis of unknown origin, including an association with exercise, predominance of 402 
Gram-positive cocci isolates and an absence of obvious origin of bacteraemia. This 403 
may reflect a shared mechanism of haematogenous microbial inoculation facilitated 404 
by localised inflammation or vasculitis. 405 
The range of synovial structures in the current study is consistent with those reported 406 
in studies of multi-aetiology synovial sepsis [5,17]. In a previous study 58% of cases 407 
of synovial sepsis of unknown origin involved the tarsocrural joint [1] but the present 408 
study does not reproduce this predominance. Nonetheless, relatively high-motion 409 
joints and tendon sheaths appear to be over represented. Case 9 of the present 410 
study was diagnosed with septic bicipital bursitis, which was rare in studies of multi-411 
aetiology synovial sepsis [1,5]. There have been numerous case reports of idiopathic 412 
or haematogenous septic bicipital bursitis in the adult horse [16,21,22,47,48]. No 413 
significant predisposing pathology was identified on bursoscopy of the horse in this 414 
study, which differs to previous reports [16,21,48]. Synovial sepsis of unknown or 415 
haematogenous origin should be considered as a differential diagnosis in adult 416 
horses with lameness originating from this region. 417 
Treatment and outcome 418 
Third generation cephalosporin antimicrobials remain above minimum inhibitory 419 
concentrations of common pathogens in synovial fluid and subcutaneous tissue for 420 
24 hours following IVRLP. However, these agents are rated as highly important by 421 
the Australian Strategic and Technical Advisory Group on Antimicrobial Resistance 422 
[56–58] and should be reserved for cases with suitable culture and susceptibility 423 
testing or exceptional cases with clinical indications [59]. Culture and susceptibility 424 
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findings from the present study suggest that third-generation cephalosporin 425 
antimicrobial agents may be valuable in cases of synovial sepsis of unknown origin, 426 
especially when isolates demonstrate resistance to other antimicrobial agents.  427 
Return to athletic function following synovial sepsis has been reported to range from 428 
54- 92% for mixed equine populations [4,5,20,60]. In the present study  55% of 429 
horses returned to racing, which is slightly greater than the 36% of Thoroughbreds 430 
reported by Schneider et al. [1]. Milner et al. [17] reported that only 63% cases from 431 
a mixed breed population with synovial sepsis of unknown origin survived to hospital 432 
discharge, compared to 88% of horses with a wound. The authors suggested that a 433 
wound results in earlier identification of pathology and reduces accumulation of 434 
synovial fluid inflammatory mediators and microbial pathogens by permitting 435 
drainage. In the present study referral and diagnosis were generally rapidly achieved 436 
despite the lack of an obvious cause of synovial sepsis. This may reflect the 437 
management of the Thoroughbred racehorse population in the present study, where 438 
horses are regularly examined for lameness.  439 
Limitations and conclusions 440 
The retrospective design of this study introduces some limitations in the availability 441 
of historical and clinical features that could offer further information on the 442 
pathophysiology of synovial sepsis of unknown origin. The infrequent nature of cases 443 
resulted in a small study population, which limited the use of some analytical 444 
methods. It is often not possible to exclude all other possible aetiologies of synovial 445 
sepsis in a clinical context. For example, it is possible that minor local pathology prior 446 
to synovial sepsis was managed routinely by stable staff and may not have been 447 
reported at presentation. Nonetheless, evidence of penetration or foreign material is 448 
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relatively frequently recognised surgically in contaminated synovial structures 449 
following traumatic inoculation, but was not identified in any case in the present 450 
series [3,5,17,61]. A prospective multi-centre study, would minimise some of these 451 
limitations and allow further characterisation of the risk factors, pathophysiology and 452 
prognosis for synovial sepsis of unknown origin when a haematogenous route is 453 
suspected.  454 
In conclusion, synovial sepsis of unknown origin is uncommon in the adult 455 
Thoroughbred racehorse and can affect a range of synovial structures.  A 456 
haematogenous origin is suspected in these cases though an origin of bacteraemia 457 
is rarely identified. With appropriate management the prognosis for return to racing is 458 
fair. 459 
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Table 1: Summary of case details and synovial fluid analysis findings for 11 cases of synovial sepsis of unknown origin in adult 651 
Thoroughbred racehorses. Abbreviations: TB, Thoroughbred, G, Gelding, M, Mare, F, Filly, S, Stallion, C, Colt, R, right, L, left, F, 652 
fore, H, hind, NR, not recorded 653 





Protein (g/L) Microbial 
culture 
Red Blood Cell 




1 3 yo TB G RH Femoropatellar joint  71.0 95 46 Positive 0.01  No 
Lateral femorotibial joint 38.5 91 51 Negative 0  No 
2 4 yo TB M RH Digital flexor tendon sheath 166.0 95 40 Positive 0.06  No 
3 2 yo TB F RF Antebrachiocarpal joint 44.8 80 49 Negative 0.02  No 
4 4 yo TB S LH Metatarsophalangeal joint 103.5 94 52 Negative 0.06  No 
5 2 yo TB F RH Femoropatellar joint 57.6 87 44 Negative 0.04  No 
Medial femorotibial joint 7.4 NR 42 NR NR  No 
Lateral femorotibial joint 8.6 NR 38 NR NR  No 
6 2 yo TB C LF Metacarpophalangeal joint 110.8 94 54 Negative 0.08  No 
7 2 yo TB F LH Femoropatellar joint 50.0 93 46 Negative 0.02  No 
8 2 yo TB G LH Tarsal sheath 38.7 96 40 Positive NR  No 
9 3 yo TB G RF Bicipital bursa 156.0 95 54 Positive 0.08  No 
10 2 yo TB F LH Tarsocrural joint 12.4 80 39 Positive NR  No 
11 6 yo TB G LF Digital flexor tendon sheath 90.8 85 60 Positive NR Yes 
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Table 2: Microbiological findings and antimicrobial susceptibility of isolates from synovial fluid of 6 cases of synovial sepsis of 654 
unknown origin in adult Thoroughbred racehorses. Abbreviations: NPO, no pathogen observed, NT, not tested, R, resistant, S, 655 
susceptible 656 





Ceftiofur Ceftriaxone Neomycin Gentamicin Amikacin Tetracycline Enrofloxacin Trimethoprim
/ sulpha 
1 NPO Coagulase positive 
Staphylococcus sp. 
S S NT S S S R S S 
2 NPO Coagulase positive 
Staphylococcus sp. 
R S NT R R NT R S S 
8 NPO Coagulase positive 
Staphylococcus sp. 





S S S R R R R S S 
10 NPO 
  
Staphylococcus xylosus R S NT S S NT S S S 
Streptococcus uberis S S NT R R NT S R S 
11 NT Streptococcus dysgalactiae 
subsp equisimilis 
S S S R R R S R S 
 657 
